| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/30/2009 | WO2007044874A3 Use of factor vii polypeptides for neuroprotection |
| 04/30/2009 | WO2007030538A3 Functionalized drugs and polymers derived therefrom |
| 04/30/2009 | WO2007022345A3 Vitamin b12 nasal spray and method of use |
| 04/30/2009 | WO2007021957A3 Fluorotaxoids |
| 04/30/2009 | WO2007021545A3 Piperazine derivatives |
| 04/30/2009 | WO2007020642A3 A method of preparing functionalized molecularly imprinted polymers using labile linking |
| 04/30/2009 | WO2007019448A3 Nitric oxide enhancing angiotensin ii antagonist compounds, compositions and methods of use |
| 04/30/2009 | WO2007016582A3 Amorphous aprepitant coprecipitates |
| 04/30/2009 | WO2007016254A3 Antineoplastic activities of ellipticine and its derivatives |
| 04/30/2009 | WO2007014327A3 Small compounds that correct protein misfolding and uses thereof |
| 04/30/2009 | WO2007014049A3 Heparin compositions and selectin inhibition |
| 04/30/2009 | WO2007011699A3 Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores |
| 04/30/2009 | WO2007006003A3 Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders |
| 04/30/2009 | WO2006138609A3 Treatment of inflammatory conditions |
| 04/30/2009 | WO2006138478A3 Stimulation of toll-like receptors on t cells |
| 04/30/2009 | WO2006130599A3 Compositions and methods for treating a damaged cardiovascular element |
| 04/30/2009 | WO2006125094A3 Combinatorial selection of phosphorothioate aptamers for rnases |
| 04/30/2009 | WO2006124358A3 Method of treating a coccidioides infection by administering an ambruticin compound |
| 04/30/2009 | WO2006121943A3 Method for the treatment of magnesium and potassium deficiencies |
| 04/30/2009 | WO2006093524A3 Antigen-carbohydrate conjugates |
| 04/30/2009 | WO2006088798A3 Modulation of hypothalamic atp-sensitive potassium channels |
| 04/30/2009 | WO2006055879A3 Novel phosphorous containing steroid mimics |
| 04/30/2009 | WO2006014405A3 Sulfonamide-based compounds as protein tyrosine kinase inhibitors |
| 04/30/2009 | WO2005120583A3 Method for preventing or treating cardiac hypertrophy |
| 04/30/2009 | WO2005113485A3 Stable nateglinide form b compositions |
| 04/30/2009 | WO2005112880A3 Compositions for enhancing biological functions in organisms |
| 04/30/2009 | WO2005109960A3 Antagonistic properties of reef fish microflora |
| 04/30/2009 | WO2005102389A9 Combinations comprising alpha-2-delta ligands and ep4 receptor antagonists |
| 04/30/2009 | WO2005070008A3 Polymer no donor predrug nanofiber coating for medical devices and therapy |
| 04/30/2009 | US20090111982 Macrocyclic compounds as inhibitors of viral replication |
| 04/30/2009 | US20090111977 Antisense compound for inducing immunological tolerance |
| 04/30/2009 | US20090111969 Macrocyclic compounds as inhibitors of viral replication |
| 04/30/2009 | US20090111896 Use of Hydrocarbon Fluids In Seed Treatment |
| 04/30/2009 | US20090111893 Method of lowering blood glucose and method of preventing or treating blood glucose and method of preventing or treating diabetes and obesity |
| 04/30/2009 | US20090111892 Rasagiline Orally Disintegrating Compositions |
| 04/30/2009 | US20090111891 Prostaglandin Analog Compositions To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111890 to stimulate hair growth, restore hair color to depigmented hair, alopecia; side effects reduction; (16-(3-chlorophenoxy)-17, 18, 19, 20-tetranor PGF2 alpha ) cyclopropyl methyl amide |
| 04/30/2009 | US20090111889 Prostaglandin Analog Compositions To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111888 to stimulate hair growth, restore hair color to depigmented hair, alopecia; side effects reduction; (16-(3-chlorophenoxy)-17,18,19,20-tetranor PGF2 alpha ) cyclopropyl amide |
| 04/30/2009 | US20090111887 Prostaglandin Analog Compositions To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111886 to stimulate hair growth, restore hair color to depigmented hair, alopecia; side effects reduction; 17-phenyl trinor PGF2 alpha cyclopropyl methyl amide |
| 04/30/2009 | US20090111885 17-phenyl trinor PGF2 alpha cyclopropylmethyl amide, for example; stimulates hair growth of scalp, eyebrows or eyelashes or restores hair color to depigmented hair |
| 04/30/2009 | US20090111884 Prostaglandin Analog Compositions And Methods To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111883 Prostaglandin Analog Compositions To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111882 Prostaglandin analog compositions and methods to treat epithelial-related conditions |
| 04/30/2009 | US20090111881 Prostaglandin Analog Compositions To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111880 Prostaglandin Analog Compositions And Methods To Treat Epithelial-Related Conditions |
| 04/30/2009 | US20090111879 Administering N-(2,6-Dichlorobenzoyl)-4-(2,6-dimethoxy-4-methoxymethylphenyl)-L-phenylalanine ethyl ester for therapy of asthma, inflammatory bowel disease, rheumatoid arthritis and atopic dermatitis |
| 04/30/2009 | US20090111878 Teeth Whitening Material and Teeth Whitening Method |
| 04/30/2009 | US20090111877 Methods for Enhancing the Quality of Life of a Senior Animal |
| 04/30/2009 | US20090111876 Extracts from chlorella |
| 04/30/2009 | US20090111875 Skin care compositions |
| 04/30/2009 | US20090111874 Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof |
| 04/30/2009 | US20090111872 Stabilized pediatric suspension of carisbamate |
| 04/30/2009 | US20090111871 Felbamate with improved bulk density |
| 04/30/2009 | US20090111870 Angelicae Sinensis Extracts Useful for Treatment of Cancers |
| 04/30/2009 | US20090111869 Benzoquinone ansamycins |
| 04/30/2009 | US20090111868 Use Of Rottlerin And Its Derivatives As Activators Of BK Channel For Therapy Of Hypertension And Related Disorders |
| 04/30/2009 | US20090111867 Indole acetic acids exhibiting crth2 receptor antagonism and uses thereof |
| 04/30/2009 | US20090111866 Novel Compounds |
| 04/30/2009 | US20090111865 Benzimidazole Derivatives, Compositions Containing Them, Preparation Thereof and Uses Thereof |
| 04/30/2009 | US20090111864 N-methyl-4-{4-[7-(4-cyano-3 -trifluoromethylphenyl)-6,8-dioxo-5,7-diazaspiro[3.4]oct-5-yl]-phenyl}butyramide; for treatment of hormone refractory prostate cancer |
| 04/30/2009 | US20090111863 Compounds, Compositions and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies |
| 04/30/2009 | US20090111862 Compound |
| 04/30/2009 | US20090111860 Sulfonamide compounds useful as adg receptor modulators |
| 04/30/2009 | US20090111859 2-(5,5-Dimethylcyclopent-1-enyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane; metabolic disorders such as type II diabetes |
| 04/30/2009 | US20090111858 Novel Alpha-(N-Sulfonamido)Acetamide Compound as an Inhibitor of Beta Amyloid Peptide Production |
| 04/30/2009 | US20090111857 1,2,4-triazole ether derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111856 Parenteral Formulation Comprising Proton Pump Inhibitor Sterilized in its Final Container by Ionizing Radiation |
| 04/30/2009 | US20090111855 SUBSTITUTED PHENOXY THIAZOLIDINEDIONES AS ESTROGEN RELATED RECEPTOR-alpha MODULATORS |
| 04/30/2009 | US20090111854 1,2,4-triazole aryl n-oxides derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111853 Fexofenadine polymorphs and process for the preparation thereof |
| 04/30/2009 | US20090111851 Antimicrobial Quinolones, Their Compositions and Uses |
| 04/30/2009 | US20090111850 Amino-Substituted Ethylamino Beta2 Adrenergic Receptor Agonists |
| 04/30/2009 | US20090111849 Crystalline salt of montelukast |
| 04/30/2009 | US20090111848 Halogenated Pyrazolo[1,5-A]Pyrimidines, Processes, Uses, Compositions and Intermediates |
| 04/30/2009 | US20090111846 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of depression, anxiety, and neurodegenerative disorders |
| 04/30/2009 | US20090111845 Treating a cancer or malignant tumor using the crystalline camptothecin ester hydrates; nontoxic |
| 04/30/2009 | US20090111844 Combination analgesic employing opioid and neutral antagonist |
| 04/30/2009 | US20090111843 Therapeutic or Prophylactic Agent for Functional Bowel Disorder |
| 04/30/2009 | US20090111842 Spirocyclic cyclohexane compounds with analgesic activity |
| 04/30/2009 | US20090111841 Novel 3,9-Diaza-Spiro[5,5]Undecane Derivatives and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors |
| 04/30/2009 | US20090111840 Heterocyclic spiro-compounds as aldosterone synthase inhibitors |
| 04/30/2009 | US20090111839 Process for Preparing Amorphous Rosuvastatin Calcium of Impurities |
| 04/30/2009 | US20090111838 6-arylamino-5-cyano-4-pyrimidinones as pde9a inhibitors |
| 04/30/2009 | US20090111837 Use of pde7 inhibitors for the treatment of neuropathic pain |
| 04/30/2009 | US20090111836 Angular Pyranocoumarins, Process for Preparation and Uses Thereof |
| 04/30/2009 | US20090111835 Thienopyrimidine and thienopyridine derivatives substituted with cyclic amino group |
| 04/30/2009 | US20090111834 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof |
| 04/30/2009 | US20090111833 Injectable meclizine formulations and methods |
| 04/30/2009 | US20090111832 Imidazolidinone Compounds Useful as Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease |
| 04/30/2009 | US20090111831 Pharmaceutical compositions |
| 04/30/2009 | US20090111830 7-Chloro-2-[(4,4-difluorocyclohexyl)methyl]-1-oxoisoindoline-5-carbonitrile, used for the treatment of schizophrenia |
| 04/30/2009 | US20090111829 Aripiprazole Salts |
| 04/30/2009 | US20090111828 L-alanine derivatives |
| 04/30/2009 | US20090111827 ARYLINDENOPYRIMIDINES COMPOUND AND USE AS AN ADENOSINE A2a RECEPTOR ANTAGONISTS |
| 04/30/2009 | US20090111826 Use of ranolazine for the treatment of cardiovascular diseases |
| 04/30/2009 | US20090111825 Thiophene 1,2,4-triazole derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111824 Amide linked heteroaromatic derivatives as modulators of mglur5 |
| 04/30/2009 | US20090111823 Aminopyridine derivatives as modulators of mglur5 |